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ABSTRACT 
Cell–extracellular matrix (ECM) interactions play major roles in controlling progenitor cell fate 
and differentiation. The receptor tyrosine kinase, discoidin domain receptor 2 (DDR2), is an 
important mediator of interactions between cells and fibrillar collagens. DDR2 signals through 
both ERK1/2 and p38 MAP kinase, which stimulate oste blast differentiation and bone 
formation. Here we show that DDR2 is critical for skeletal development and differentiation of 
marrow progenitor cells to osteoblasts while suppressing marrow adipogenesis. Smallie mice 
(Ddr2slie/slie), which contain a nonfunctional Ddr2 allele, have multiple skeletal defects. A 









wild-type (WT), Ddr2wt/slie, and Ddr2slie/slie mice were compared. These changes were associated 
with reduced trabecular number (Tb.N) and trabecular thickness (Tb.Th) and increased 
trabecular spacing (Tb.Sp) in both males and females, but reduced cortical thickness only in 
Ddr2slie/slie females. Bone changes were attributed to decreased bone formation rather than 
increased osteoclast activity. Significantly, marrow fat and adipocyte-specific mRNA expression 
were significantly elevated in Ddr2slie/slie animals. Additional skeletal defects include widened 
calvarial sutures and reduced vertebral trabecular bone. To examine the role of DDR2 signaling 
in cell differentiation, bone marrow stromal cells (BMSCs) were grown under osteogenic and 
adipogenic conditions. Ddr2slie/slie cells exhibited defective osteoblast diversity andccelerated 
adipogenesis. Changes in differentiation were related to activity of runt-related transcription 
factor 2 (RUNX2) and PPARγ, transcription factors that are both controlled by MAPK-
dependent phosphorylation. Specifically, the defectiv  osteoblast disparity in calvarial cells from 
Ddr2slie/slie mice was associated with reduced ERK/MAP kinase and RUNX2-S319 
phosphorylation and could be rescued with a constitutively active phosphomimetic RUNX2 
mutant. Also, DDR2 was shown to increase RUNX2-S319 phosphorylation and transcriptional 
activity while also increasing PPARγ-S112 phosphorylation, but reducing its activity. DDR2 is, 
therefore, important for maintenance of osteoblast activity and suppression of marrow 
adipogenesis in vivo and these actions are related to changes in MAPK-dependent RUNX2 and 
PPARγ phosphorylation. © 2016 American Society for Bone a d Mineral Research 
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Introduction 
Extracellular matrix (ECM) signals have profound effects on the differentiation of many cell 
types. In bone, disparity of mesenchymal progenitor cells to osteoblasts requires interaction of 
progenitor cells with a type I collagen-containing ECM, a response that is in part mediated by 
α1β1 and α2β1 integrins.(1–4) However, the relatively mild bone phenotypes observed with 
knockout or inactivation of collagen-binding integrins in vivo suggest involvement of other 
collagen-binding molecules.(5,6) 
 Discoidin domain receptors (DDRs) are a second class of collagen receptors that differ from 
integrins in having intrinsic tyrosine kinase activity and selective affinity for triple-helical, native 
fibrillar and nonfibrillar collagens. DDR1 is of epithelial origin and has a broad ligand specificity, 
which includes all known collagens, whereas DDR2 is expressed by mesenchymal cells and 









range of cell functions related to development, ECM turnover, growth regulation, and cancer (for 
reviews, see(7,9)). Two lines of genetic evidence suggest a role for DDR2 in bone. First, human 
DDR2 mutations cause spondylo-meta-epiphyseal dysplasia (SMED), a skeletal disorder 
associated with dwarfism, short fingers, bowing of long bones, abnormal calcifications, and 
craniofacial abnormalities.(10,11) In addition, polymorphisms in DDR2 are associated with low 
bone mineral density (BMD) and fracture risk in a Hn Chinese population.(12) Mice harboring 
deletions in the Ddr2 locus have a SMED-like phenotype characterized by warfism and 
reduction in total BMD.(13,14) However, the detailed bone phenotype of these animals has not 
been reported. Transgenic manipulation of Ddr2 also affects body mass index (BMI) and 
adiposity,(14,15) suggesting possible additional effects of this receptor on energy metabolism. 
 Significantly, after collagen activation, DDR2 proagates downstream signals using the 
ERK1/2 and p38 MAP kinase pathways,(16,17) which are also required for normal skeletal 
development.(18–20) The ERK1/2 MAP kinase pathway affects osteoblast function by selectively 
phosphorylating runt-related transcription factor 2 (RUNX2), a key transcription factor 
controlling differentiation of osteoblast from mesenchymal progenitor cells. ERK1/2 binds and 
phosphorylates RUNX2 on several serine residues including S301 and S319, which are both 
required for RUNX2-dependent transcription.(21) These phosphorylation events are necessary for 
the response of bone to several important stimuli inc uding ECM synthesis, mechanical loading, 
FGF2, and BMP treatment.(21–23) Similarly, PPARγ undergoes ERK-dependent phosphorylation 
at S112, resulting in decreased PPARγ transcriptional activity.(24) As we recently showed, 
activation of MAPK activity in mesenchymal cells both increases osteoblast distinction and 
suppresses adipogenesis, actions that require intact MAPK-dependent phosphorylation of 









osteoblast and adipocyte differentiation via MAPK-dependent phosphorylation. To test this 
hypothesis, we examined the bone and marrow fat phenotypes of Ddr2-deficient mice and 
showed that actions of DDR2 on osteoblast and adipocyte disparity can be explained by the 
selective regulation of RUNX2 and PPARγ. 
 










Smallie mice, which contain a spontaneous deletion in Ddr2, were initially obtained from the 
Jackson Laboratory on a C57BLS/J (BKS) background (BKS(HRS-Ddr2slie/JngJ). Mice were 
bred with C57BL/J6 (B6) mice for at least 10 generations. Unlike mice on the BKS background 
that are sterile when homozygoic (Ddr2slie/slie), homozygotes on the B6 background bred 
normally with normal litter sizes (results not shown). Nevertheless, mutant mice of both sexes 
retained the dwarf phenotype described on the BKS background (Supporting Fig. 1A–C). Female 
and male mice were genotyped using previously defined PCR primers and maintained on a 
normal chow diet until sacrifice at 3 or 5 months for analysis of skeletal and marrow fat 
phenotypes. Mice were used for skeletal analysis, RNA isolation and as a source of calvarial 
osteoblasts, marrow stromal cells (MSC), and marrow macrophage cultures. All animal studies 
were approved by the University of Michigan Committee on the Use and Care of Animals 
(UCUCA) and conformed to all guidelines and regulations for the protection of animal subjects. 
Mice were housed in specific pathogen-free Association for Assessment and Accreditation of 
Laboratory Animal Care ( AAALAC)-certified facilities. After genotyping, littermates were 
assigned to the experimental groups indicated. 
Micro–computed tomography analysis of bone 
Trabecular and cortical bone parameters were measurd by micro–computed tomography (µCT) 
using a Scanco Model 100 (Scanco Medical AG, Bassersdorf, Switzerland). Scan settings were: 
voxel size 12 µm, 70 kVp, 114 µA, 0.5 mm AL filter, and integration time 500 ms. All scans 
were analyzed using fixed thresholds (180 for trabecular bone and 280 for cortical bone). 









proximal tibia and the anterior end of L3 vertebrae. Cortical data were collected from 30 sections 
above trabecular bone of tibia and fibula junction. 
Analysis of bone marrow fat accumulation 
After µCT scanning and calculation of osseous parameters and an accurate marrow volume, 
samples were decalcified with 10% ethylenediaminetetraacetic acid. After fixation with 10% 
neutral buffered formalin for 24 hours, the samples w re incubated with 1% osmium tetroxide at 
room temperature for 2 hours to stain marrow fat. Osmium staining was measured by µCT 
analysis.(26) 
 
Dynamic histomorphometry and osteoclast analysis 
For dynamic bone histomorphometry, 12-week-old mice were intraperitoneally injected with 30 
mg/kg calcine 9 days before sacrifice and then with10 mg/kg Alizarin Red 2 days before 
sacrifice. Tibias were harvested and embedded with methyl methacrylate. Six micron sections 
were cut using a Leica SM2500 metallurgical cutting system. For the measurement of in vivo 
osteoclast activity, tibias were harvested from 12-week-old mice. Tartrate-resistant acid 
phosphatase (TRAP) staining was performed on histological sections using the Sigma Trap 
staining kit (387-A). The fluorescence and TRAP stained images were photographed using a 
Nikon 50i microscope. Histomorphometric parameters fo  double labels and osteoclast activity 
were assessed using an OsteoMeasureXP system (OsteoMetrics, Decatur, GA, USA). 
 
Cell cultures and in vitro differentiation 
Primary calvaria osteoblasts and bone marrow stromal cells (BMSCs) were isolated from 12-









α modified essential medium/10% fetal bovine serum (α-MEM/10% FBS) containing 50 µg/mL 
ascorbic acid and 10 mM β-glycerophosphate. For adipogenesis, cells were grown f r 2 days in 
α-MEM containing 10% FBS, insulin (5 µg/mL), dexamethasone (1 µM), IBMX (500 µM), and 
troglitazone (5 µM), followed by growth in a medium containing troglitazone (5 µM) for 9 days. 
To stain mineral, cells were incubated at room temprature in 2% Alizarin Red S (pH 4.2 with 
10% ammonium hydroxide) for 0.5 hours. For measurement of fat-droplet accumulation, fixed 
cells were incubated with 60% isopropyl alcohol for 10 min, then stained with 2 mg/mL Oil Red 
O for 1 hour. For in vitro osteoclast differentiation, bone marrow macrophages (BMM) were 
isolated from tibias and femurs of 12-week-old mice using the method of Mizoguchi and 
coworkers(30) and treated with 10 ηg/mL M-CSF and 50 ηg/mL RANKL for 3 days.(31) For 
measurement of osteoclast induction, cells were stained for TRAP (Sigma staining kit; Sigma-
Aldrich, St. Louis, MO, USA) or grown on BioCoat Osteologic dishes (BD Biosciences, San 
Jose, CA, USA) for 3 days before measurement of pit formation. Cell images were taken using 
an inverted phase contrast microscope (Nikon D300). Osteoblasts and adipocyte-specific mRNA 
expression were assessed by real-time RT-PCR and normalized to GAPDH as previously 
described.(25) The following mRNAs were measured: Bglap2, Ibsp, and Runx2 mRNAs for 
osteoblasts and Pparg, Cebpa, Adipoq, and Fabp4 for adipocytes. Western blot analysis was 
performed using standard procedures. Sources for antibodies were as follows: total RUNX2 
antibody, MBL; PPARγ phospho-S112-specific antibody and total PPARγ antibody, Millipore; 
phospho-ERK1/2 and total ERK1/2 antibody, Cell Signaling. RUNX2 phospho-S319-specific 
antibody was previously described.(22) Phosphorylation at this site is closely correlated with 











The 6OSE2-Luc reporter, pCMV wild-type (WT) RUNX2 (RUNX2-WT), S301,319A RUNX2 
(RUNX2-SA), and S301,319E RUNX2 (RUNX2-SE) expression vectors were previously 
described,(21) as were ARE-Luc, RXR, wild-type PPARγ (PPARɣ-WT) and S112A PPARγ 
vectors (PPARγ-SA).(32,33) WT, dominant-negative, and constitutively active DDR2 expression 
vectors were a generous gift from Dr. Scott Friedman, Mt. Sinai School of Medicine, New York, 
NY, USA.(34) For lentivirus production, cDNAs encoding WT RUNX2, RUNX2-SA, or 
RUNX2-SE were subcloned into pLenti-GFP-puro (Addgene #17448) and packaged by the 
University of Michigan Vector Core, Ann Arbor, MI, USA. Calvarial cells were isolated from 
12-week-old WT and Ddr2slie/slie mice, transduced with lentivirus vectors, and stable cell lines 
were developed by selection in 100 µg/mL puromycin for 4 weeks. To measure effects of DDR2 
on RUNX2 and PPARγ transcriptional activity, COS7 cells were transfected with the indicated 
expression plasmids and either 6OSE2-Luc (RUNX2 report r) or PPRE-Luc (PPARγ reporter), 




All statistical analyses were performed using SPSS version 16.0 Software (SPSS, Inc., Chicago, 
IL, USA). Unless indicated otherwise, each reported value is the mean ± SD of triplicate 
independent samples for in vitro cultures or at least six animals per group for in vivo studies. 











Reduced trabecular bone in the appendicular and axial skeletons of Ddr2slie/slie mice is explained 
by a selective defect in bone formation 
Smallie mice contain a 150-kilobase (kb) deletion in the Ddr2 locus that includes most of the 
coding sequence (17 out of 18 exons deleted), resulting in a loss of function allele.(14) Like 
SMED patients, these animals are dwarfed and have reduced total bone mass but, otherwise, 
their bone phenotype has not been characterized. To further define the skeletal phenotype of 
Smallie mice, µCT was used to examine tibias from WT, Ddr2wt/slie, and Ddr2slie/slie animals. 
Tibias of 3- and 5-month-old mice showed major decreases in trabecular bone that were 
proportional to gene dose in both genders (females in Supporting Fig. 2 and Fig. 1, and males in 
Supporting Fig. 3). For example, in 5-month-old females Ddr2wt/slie mice exhibited a 35% 
decrease in bone volume/total volume (BV/TV) relative to WT controls, whereas this parameter 
was decreased nearly 70% in Ddr2slie/slie animals (Fig. 1B). These changes were accompanied by 
expected reductions in trabecular number (Tb.N) and thickness (Tb.Th), and increased trabecular 
spacing (Tb.Sp) (Fig. 1C–E). In addition, a 7% decrease in cortical bone was observed in 
females, but not in males (compare Fig. 1F with Supporting Fig. 3F). Changes in bone mass 
were accompanied by a gene dosage-related decline in mineral apposition rate (MAR) and bone 
formation rate (BFR) (Fig. 1G–I), osteoblast marker (Runx2, Bglap2, and Ibsp) mRNA levels 
(Fig. 1J–L), and serum osteocalcin when Ddr2wt/slie and Ddr2slie/slie mice were compared with WT 
(Fig. 1M). Ddr2slie/slie mice also had large reductions in vertebral trabecular bone. Micro–
computed tomography analysis of the third lumbar vertebrae revealed 20% and 60% declines in 
BV/TV in Ddr2wt/slie and Ddr2slie/slie mice, respectively (Supporting Fig. 4). 









Two approaches were used to determine if the decreased bone in Ddr2slie/slie mice was in part 
explained by changes in bone resorption: (1) TRAP staining was used to measure osteoclast 
surface and numbers in tibia; and (2) the ability of bone marrow macrophage cultures to undergo 
osteoclast differentiation was measured. No differences were seen in osteoclast surface, 
osteoclast number, or osteoclast number/osteoclast surface. In addition, the serum bone 
resorption markers CTx-1 and TRAP were not affected by Ddr2 status (Supporting Fig. 5A–F). 
Furthermore, after growth of BMM in medium containing M-CSF and RANKL to induce 
osteoclast formation, no differences were observed between groups in terms of TRAP-positive 
cells/dish or mineral resorption measured using BioCoat dishes (Supporting Fig. 6A–D). Finally, 
equivalent levels of two osteoclast marker mRNAs, Ct k and Nfatc1, and culture medium levels 
of CTx-1 and TRAP were detected in all groups (Supporting Fig. 6E–H). Thus Ddr2 deletion in 
vivo preferentially affects bone formation without noticeably altering osteoclast activity. 
 
The reduced bone in Ddr2slie/slie mice is associated with increased marrow fat 
Histological examination of bones from Ddr2wt/slie and Ddr2slie/slie mice often showed regions 
containing apparent adipocytes (Supporting Fig. 5A). To quantify this marrow fat, tibia from 5-
month-old female mice were stained with the lipophilic compound osmium tetroxide, and tibial 
marrow fat was visualized by µCT.(26) As shown in Fig. 2, marrow fat increased in proximal and 
distal regions. Specific quantitation of osmium density in the proximal tibia revealed a more than 
fivefold increase in marrow adipose tissue when WT, Ddr2wt/slie and Ddr2slie/slie mice were 
compared (Fig. 2B–D). Gene expression profiles of whole bone also confirmed a shift from 









mRNAs (compare Fig. 1J–L with Fig. 2E–H). In addition, serum adiponectin levels increased in 
parallel with Adipoq mRNA, whereas serum leptin decreased (Fig. 2I, J). 
<Insert Figure 2> 
 
Impaired osteoblast differentiation and increased adipogenesis in BMSCs from Ddr2slie/slie mice 
To determine the requirement for DDR2 in the distinction of marrow progenitors to osteoblasts 
or adipocytes, BMSCs from WT and Ddr2slie/slie mice were grown in osteoblast or adipocyte 
induction conditions (Fig. 3). Cells from Ddr2slie/slie mice formed fewer mineralized nodules and 
expressed lower levels of osteoblast marker mRNAs (Fig. 3A–D). In contrast, they formed 
increased numbers of lipid droplet-containing cells and expressed higher levels of adipocyte 
markers (Fig. 3E–I). Although DDR2 has been reported to affect cell pro iferation in other cell 
types such as fibroblasts, no major differences in proliferation rates were observed when BMSCs 
from wild-type and Ddr2slie/slie mice were compared (Supporting Fig. 1D). 
<Insert Figure 3> 
 
Defective calvarial mineralization and osteoblasts contrast in Ddr2slie/slie mice 
In addition to the defects in the appendicular and xial skeleton noted above, skulls from 
newborn Ddr2slie/slie mice had widened sutures and were poorly mineralized, such that total 
cranial bone volume was reduced by approximately 40% (Fig. 4A, B). In addition, calvarial 
osteoblasts from these mice, like BMSCs, formed few mineralized nodules and expressed lower 
levels of osteoblast marker mRNAs than cells from WT littermates (Fig. 4C–F). 
 









MAPK activation in mesenchymal cells both increases osteoblast differences and inhibits 
adipogenesis via phosphorylation of RUNX2 and PPARγ.(22) Because MAPK is a major DDR2-
activated downstream signal,(16,17) we hypothesized that reduced MAPK signaling in DDR2-
deficient cells could explain the observed decrease in osteoblast differentiation and increase in 
adipogenesis. This hypothesis was evaluated in two ways. We: (1) examined the role of RUNX2 
phosphorylation in the differentiation of calvarial cells from WT and DDR2-deficient mice; and 
(2) directly measured the ability of DDR2 to regulate RUNX2 and PPARγ phosphorylation and 
transcriptional activity. 
 In agreement with our previous report,(22) MAP kinase activity (P-ERK/total ERK) and 
RUNX2 phosphorylation (P-RUNX2/total RUNX2) gradually increased during calvarial 
osteoblast differentiation. This increase was accompanied by a parallel increase in DDR2 protein 
(Fig. 4G–I). Consistent with their reduced differentiation potential, DDR2-deficient cells had 
much lower levels of MAP kinase activity and RUNX2 phosphorylation. To determine if this 
could explain the observed suppression of osteoblast diversity in cells from Ddr2slie/slie mice, we 
compared the activity of WT (RUNX2-WT), phosphorylation site mutant (RUNX2 S301,S319A; 
RUNX2-SA), and phosphorylation site mimetic (RUNX2 S301,S319E; RUNX2-SE) forms of 
RUNX2 in WT or DDR2-deficient cells (Fig. 4J–L). Lentiviral transduction was used to generate 
stable cell lines that were then grown in osteoblast disparate conditions for 2 weeks before 
measurement of osteoblast mRNAs. Consistent with previous findings,(21) overexpression of WT 
RUNX2 in DDR2-sufficient (WT) cells strongly induced Ibsp and Bglap2 mRNAs, whereas 
levels were reduced by approximately 50% in cells expr ssing the phosphorylation-deficient 
mutant (RUNX2-SA). As would be expected if RUNX2 phosphorylation was necessary for 









(DDR2) cells regardless of whether they were expressing WT or phosphorylation-deficient 
RUNX2. Similarly, in cells expressing the phosphorylation mimetic RUNX2 (RUNX2-SE), 
which does not require phosphorylation for full activity, both Bgalp2 and Ibsp mRNAs were 
expressed at high levels regardless of DDR2 status. 
<Insert Figure 4> 
 Effects of DDR2 on RUNX2 and PPARγ transcriptional activity measured using luciferase 
reporters are shown in Fig. 5. In cells transfected with WT RUNX2, WT DDR2 and, to a greater 
extent, a constitutively active DDR2 mutant increased RUNX2 phosphorylation (P-RUNX2/total 
RUNX2) and transcriptional activity whereas a dominant-negative DDR2 mutant had no effect 
(Fig. 5A, B). As expected, DDR2 also increased MAPK activity (P-ERK) without affecting either 
total RUNX2 or ERK levels. The RUNX2 response required MAPK-dependent phosphorylation 
because the RUNX2-SA mutant was resistant to DDR2 regulation. Similarly, DDR2 actions on 
PPARγ transcriptional activity are explained by a mechanism involving MAPK-dependent 
phosphorylation (Fig. 5C, D). In this case, a WT or constitutively active DDR2 increased PPARγ 
S112 phosphorylation with concomitant inhibition of reporter activity whereas a dominant-
negative mutant was inactive. In contrast PPARγ, containing an S112A mutation rendering it 
resistant to MAPK-dependent inhibition, had higher basal activity and was not inhibited by 
DDR2 overexpression. 
<Insert Figure 5> 
 
Discussion 
Here we describe the skeletal and marrow fat phenotypes of Ddr2-deficient mice and relate these 









Although absence of DDR2 inhibits growth and body size, effects previously attributed to 
reduced proliferation of growth plate chondrocytes,(13) our studies clearly show that DDR2 is 
also required for normal trabecular bone formation in the absence of changes in resorption. 
Furthermore, loss of DDR2 increases marrow adipogenesis and alters serum levels of the 
adipocyte-related hormones adiponectin and leptin. 
 This study provides the first in vivo evidence that DDR2 increases bone mass largely by 
increasing osteoblast differentiation and bone formation. Specifically, bone formation in 
Ddr2slie/slie mice was shown to be dramatically reduced, leading to decreased trabeculae in long 
bones and vertebrae. Consequently, osteoblast differentiation was reduced in BMSCs and 
calvarial cells from Ddr2-deficient mice due to a reduction in ERK/MAP kinase signaling and 
RUNX2 phosphorylation. The concept that DDR2 stimulates bone formation through MAP 
kinase and RUNX2 was originally proposed by Zhang ad coworkers on the basis of studies with 
osteoblast and chondrocyte cell lines.(35) In their study, DDR2 was shown to increase MAP 
kinase activity and phosphorylation of RUNX2 at Ser301 and Ser 319,(35) sites previously 
identified by us as being essential for MAPK-dependent RUNX2 transcriptional activity.(21) 
More recently, the same group proposed, largely on the basis of cell culture studies, that DDR2 
can also suppress osteoclastogenesis and showed that overexpression of DDR2 in bone marrow 
could reverse ovariectomy-induced bone loss.(36) Whereas our studies provide in vivo validation 
of the former concept, we failed to obtain evidence for defective osteoclast formation in 
Ddr2slie/slie mice. These animals had normal levels of bone-associated osteoclasts and serum 
resorption markers. Furthermore, osteoclast differentiation from bone marrow macrophages as 
measured by induction of osteoclast markers or bone resorbing activity (resorptive pit formation) 









osteoblast differentiation and bone formation. Although it is difficult to directly compare our in 
vivo results with this previous work, a possible reason for this apparent discrepancy might be 
compensation for loss of DDR2 when it is absent during all stages of osteoclast development in 
vivo that does not occur when DDR2 is knocked down with shRNA during differentiation of 
osteoclasts in vitro. 
 In the initial report describing Ddr2slie/slie mice, homozygous animals were found to be sterile 
due to gonadal insufficiency in both males and femal s.(14) Although all pituitary and 
hypothalamic hormones and releasing factors were normal as was circulating IGF-1, secreted 
steroid hormones were reduced in both genders. Clearly, reduced steroid hormone levels would 
be expected to affect bone metabolism as well as reproduction. Nevertheless, we do not think 
this explains our results. As noted in Materials and Methods, when originally characterized, 
smallie mice were on a BKS background; all our studies used B6 mice, which bred normally 
even as Ddr2slie/slie homozygotes (see Materials and Methods). Although we have not measured 
circulating steroid hormone levels, they are indeed sufficient for gender maturation and function. 
Moreover, our failure to observe defects in osteoclastogenesis in females is certainly 
incompatible with a major reduction in gender steroids. Thus the reproductive defects associated 
with the absence of DDR2 are likely mouse line-specific. Nonetheless, a more detailed 
understanding of the functions of DDR2 in bone will require the development of a tissue-specific 
knockout model that is currently under development in our laboratory. 
 Our observation that marrow adipose tissue is dramatically increased in Ddr2slie/slie mice is 
of particular interest, in that marrow adiposity is associated with many skeletal diseases 
including osteoporosis and disuse osteopenia.(37–39) Previous analysis of Ddr2slie/slie mice detected 









levels. However, marrow fat was not examined.(14) Paradoxically, transgenic overexpression of 
Ddr2 in all tissues also decreased BMI and epididymal fat pad weight while decreasing serum 
LDL-cholesterol, albumin, and uric acid but, again, marrow fat was not analyzed.(15) 
 As we recently showed, differentiation of mesenchymal cells into osteoblasts or adipocytes 
is reciprocally controlled by the relative activity of RUNX2 and PPARγ, transcription factors 
that are both regulated by MAP kinase-dependent phosphorylation.(25) Specifically, 
phosphorylation of RUNX2 at Ser 301 and Ser 319 increases transcriptional activity and 
osteoblast differentiation, whereas phosphorylation of PPARγ at Ser 112 inhibits its activity and 
blocks adipogenesis. This pathway provides a plausible mechanism to explain how DDR2, acting 
through MAP kinase, increases bone formation and suppresses marrow adipogenesis. As shown 
in Fig. 5, DDR2 stimulates phosphorylation of both RUNX2 and PPARγ leading to increased 
RUNX2-dependent transcriptional activity and decreased PPARγ-dependent transcription. Also, 
as would be predicted, MAP kinase activity, RUNX2 phosphorylation, and osteoblast 
differentiation are reduced in calvarial cultures from Ddr2slie/slie mice. The decreased osteoblast 
differentiation in DDR2-deficient cells was explained by a defect in RUNX2 phosphorylation 
that was likely a consequence of the reduced MAPK activity in these cells; differences in 
RUNX2-dependent gene expression in wild-type versus DDR2-deficient cells were not seen in 
cells containing a phosphorylation-deficient RUNX2 mutant (RUNX2 S301,319A), whereas a 
phosphomimetic mutant (RUNX2 S301,319E) restored transcriptional activity to the same levels 
in wild-type or DDR2-deficient cells (Fig. 4J–L). 
 Notably, MAPK activity, RUNX2 phosphorylation, and osteoblast differentiation are only 
partially inhibited in cells from Ddr2slie/slie mice (Fig. 4G–I). This indicates that DDR2 is not the 









Introduction, collagen-binding integrins can also stimulate osteoblast disparity and they likely 
account for the residual osteoblast distinction and bone formation in the absence of DDR2. 
 The observation that DDR2 can affect peripheral and marrow fat, as well as the adipokines 
adiponectin and leptin, proposes that DDR2 may also participate in the regulation of energy 
metabolism, possibly through its action on marrow adipose tissue. Recent studies showed that 
marrow fat is a major source of circulating adiponectin and manipulations that alter marrow 
adiposity can also affect adiponectin levels.(40) Accordingly, it is possible that the increased 
serum adiponectin we observed in Ddr2slie/slie mice may be related to the increased marrow 
adipose tissue in these animals and that changes in adiponectin may explain the reported 
decrease in BMI in the absence of DDR2.(14) Nevertheless, further studies will be required to 
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Fig. 1. Decreased trabecular and cortical bone, bone formation, and osteoblast gene 
expression in Ddr2slie/slie mice. Trabecular and cortical bone parameters were measured by 
µCT in 5-month-old Ddr2wt/wt (wild-type [WT]), Ddr2slie/wt (hetero), or Ddr2slie/slie (homo) 
female mice. (A) Representative µCT images of tibia showing trabecular and cortical bone. 
(B–E) Measurements are shown for trabecular bone volume over total volume (BV/TV), 
trabecular number (Tb.N), trabecular thickness (Tb.Th, mm) and trabecular spacing (Tb.Sp, 
mm). (F) Cortical BV/TV. (G–I) Dynamic bone histomorphometry. For measurement of 
bone formation parameters, 12-week-old female mice were injected with calcine and 
Alizarin Red followed by measurement of mineral apposition rate (MAR) and bone 
formation rate (BFR). Representative fluorescent images are shown in (G). (J–L) Osteoblast 
marker mRNAs. RNA was extracted from whole bones of 5-month-old females and the 
following mRNAs were measured: Runx2, Bglap2, and Ibsp. (M) Serum levels of total 
osteocalcin (Bglap2). n = 8/group; statistically significant at *p < 0.01. 
 
Fig. 2. Increased marrow adipose tissue in tibias from 5-month-old female Ddr2slie/slie mice. 
Analysis used the same samples as Fig. 1A–F. (A) Micro–CT images of osmium-stained 
demineralized tibias from wild-type (WT), heterozygous, and homozygous Ddr2slie/slie mice 
showing landmarks used to calculate multifocal atrial achycardia (MAT) in the proximal tibias 
(dashed lines). (B–D) Measurement of total osmium-positive volume (OSM, mm3), total bone 
volume (TV, mm3), and osmium-positive volume/total bone volume (OSM/TV). (E–H) 
Adipocyte marker mRNA levels from whole bone: Pparg mRNA (E), Cebpa mRNA (F), Fabp4 
mRNA (G), and dipoq mRNA (H). (I, J) Measurement of serum adipocyte marker proteins by 










Fig. 3. Decreased osteoblast and increased adipocyte differentiation in BMSCs from Ddr2slie/slie 
mice. BMSCs were isolated from 12-week-old wild-type (WT) and homozygous Ddr2slie/slie 
female mice (DDR2) and grown in osteogenic (A–D), or adipogenic conditions (E–I). (A) 
Mineralization. Cells were stained with Alizarin Red after 3 weeks in culture. (B–D) Osteoblast 
differentiation marker mRNAs: (B) Runx2 mRNA, (C) Bglap2 mRNA, and (D) Ibsp mRNA. (E) 
Lipid-droplet accumulation. Cells were stained with Oil Red O after 9 days in culture. (F–I) 
Adipocyte differentiation marker mRNAs: (F) Pparg mRNA, (G) Cebpa mRNA, (H) Adipoq 
mRNA, and (I) Fabp4 mRNA. 
 
Fig. 4. Defective calvarial mineralization and osteoblast differentiation in Ddr2slie/slie mice are 
related to reduced RUNX2 phosphorylation. (A, B) Micro–CT (µCT) analysis of calvaria from 
newborn mice. (A) Representative µCT images. (B) Calculation of total bone volume (BV, mm3). 
(C–I) Osteoblast differentiation. Calvarial osteoblasts were isolated from 12-week-old wild-type 
(WT) or homozygous Ddr2slie/slie female mice and grown in osteogenic medium for the tim s 
indicated. (C) Alizarin Red staining of 2-week-old calvaria cell cultures. (D–F) Osteoblast 
differentiation marker mRNAs: (D) Runx2 mRNA, (E) Bglap2 mRNA, and (F) Ibsp mRNA. (G–
I) Western blot quantitation of DDR2, phosphorylated RUNX2, total RUNX2, phosphorylated 
ERK1/2, and total ERK1/2. (J-L) Analysis of stable cell lines from WT and Ddr2slie/slie mice 
expressing control vector (GFP), WT RUNX2, phosphorylation site mutant RUNX2 (RUNX2 
S301,319A; SA), or phosphorylation site mimetic RUNX2 (RUNX2 S301,319E; SE). Stable cell 
lines were established using lentivirus transduction as described in Materials and Methods, and 









were measured after growth in osteoblast differentiation conditions. n = 8/group; statistically 
significant at *p < 0.01. 
 
Fig. 5. Reciprocal control of RUNX2 and PPARγ transcriptional activity by DDR2-dependent 
phosphorylation. (A, B) RUNX2 regulation. COS7 cells were transfected with a RUNX2 reporter 
plasmid (6OSE2-Luc) and expression vectors encoding w ld type (WT) (Runx2-WT) or 
phosphorylation site mutant RUNX2 (Runx2 S301A/S319A), and empty vector (EV), WT, or 
constitutively active (CS) DDR2. (A) Normalized luciferase activity. (B) Immunoblot of 
RUNX2-S319-P, total RUNX2, P-ERK, and total ERK. Values under each lane indicate ratios or 
P-RUNX2/total RUNX2 and P-ERK/total ERK as measured by densitometry. (C, D) PPARɣ 
regulation. Cells were transfected with PPARγ reporter/RXR combination (PPRE-Luc) as 
described in Materials and Methods, together with expr ssion vectors encoding WT (PPAR-WT) 
or phosphorylation site mutant PPARγ (PPAR-S112AA) and EV, WT, or CS DDR2. (C) 
Normalized luciferase activity. (D) Immunoblot of PPARγ-S112-P, total PPARγ, P-ERK, and 
total ERK. 
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